SCHEMBL12432018

SCHEMBL12432018

OB(O)c1cc2c3ccccc3c(N(c3ccccc3)c3ccccc3)cc2c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA7 P43166 1/20 0.34
ENPP2 Q13822 1/20 0.34
CA14 Q9ULX7 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 2/20 0.33
LIPG Q9Y5X9 1/20 0.32
MGLL Q99685 2/20 0.32
GAA P10253 1/20 0.32
LIPE Q05469 1/20 0.31
ALDH1A1 P00352 2/20 0.31
GLA P06280 1/20 0.31
TSHR P16473 1/20 0.31
L3MBTL1 Q9Y468 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31142139 0.85 ALDH1A1 (0.39) TP53MAPTGAAALDH1A1GLA
SCHEMBL134697 0.85 ALDH1A1 (0.39) TP53MAPTGAAALDH1A1GLA
SCHEMBL30536929 0.82 CA4 (0.37) CA4CA6CA5ACA7ENPP2
SCHEMBL17699111 0.82 CA4 (0.37) CA4CA6CA5ACA7ENPP2
SCHEMBL28719182 0.81 SIGMAR1 (0.37) CA4CA6CA5ACA7ENPP2
SCHEMBL2399644 0.79 MAPT (0.46) CA4CA6CA5ACA7ENPP2
SCHEMBL24010998 0.79 CYP2C19 (0.39) TP53MAPTALDH1A1TSHRL3MBTL1
SCHEMBL2535341 0.79 CYP2C19 (0.39) TP53MAPTALDH1A1TSHRL3MBTL1
SCHEMBL6123603 0.79 MEN1 (0.39) CA4CA14MAPTALDH1A1GLA
SCHEMBL14505900 0.79 CHKA (0.39) MAPTALDH1A1TSHRL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981525-B2 Naphthalene compound and organic light-emitting device using the compound CANON KABUSHIKI KAISHA (JP) 2011-07-19 US disclosed
US-7981525-B2 Naphthalene compound and organic light-emitting device using the compound CANON KABUSHIKI KAISHA (JP) 2011-07-19 US disclosed
US-20080224603-A1 NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2008-09-18 US disclosed
US-20080224603-A1 NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND CANON KABUSHIKI KAISHA (JP) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080224603-A1 NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND AHR, CRY1, NR2E3 CA4 2914/4885CA6 3468/4885CA5A 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.